AC699

N/A

Report date: 2025/04/09 13:56:55
NME

Base Information

Drug NameAC699
Drug Alias NameAC-699AC-0699
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionEstrogen receptors degraders
TargetsEstrogen receptors
Therapy Area/IndicationsMetastatic breast cancerBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAccutar Biotechnology Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAccutar Biological Science And Technology (Shanghai) Co LtdAccutar Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A